Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain
스파이크 수용체 결합 도메인의 특정 에피토프를 표적으로 하는 단일클론항체에 의한 SARS-CoV-2 감염의 중화 또는 증강
Article
[키워드] abrogated
ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Alanine
Alpha
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
antibody
Antibody-dependent enhancement
binding
binding epitope
caused
cellular
contrary
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cross-reactivity
Delta
demonstrated
dose-dependent manner
ELISA
epitope
Epitopes
Epsilon
exhibited
exhibiting
experiment
Gamma
HEK293T cells
Infection
lentivirus
MERS-CoV
monoclonal antibodies
monoclonal antibody
mouse monoclonal antibody
NAbs
Neutralizing activity
Neutralizing antibodies
neutralizing antibody
Prophylactic
Protein
pseudotyped
RBD
receptor
Receptor binding domain
Receptor-binding domain
reduction
Region
reported
residue
residues
respiratory
S protein
S proteins
SARS-CoV
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike
SARS-CoV-2 variant
SARS-CoV-2 variants
severe acute respiratory syndrome Coronavirus
spike
Spike receptor binding domain
Spike receptor binding domain.
spike receptor-binding domain
the RBD
the receptor-binding domain
the S protein
Therapeutic treatment
variant
variants of SARS-CoV-2
wild-type
[DOI] 10.1016/j.antiviral.2022.105290 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.antiviral.2022.105290 PMC 바로가기 [Article Type] Article